Jane Street Group, LLC Cytokinetics Inc Call Options Transaction History

Jane Street Group, LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$51.22 - $60.16 $8.01 Million - $9.41 Million	156,400 New	156,400 $8.26 Million
Q1 2022 May 17, 2022	BUY	$29.74 - $46.0 $1.48 Million - $2.29 Million	49,800 Added 137.57%	86,000 $3.17 Million
Q4 2021 Feb 15, 2022	SELL	$34.35 - $46.38 $3.29 Million - $4.44 Million	-95,800 Reduced 72.58%	36,200 $1.65 Million
Q3 2021 Nov 16, 2021	BUY	$18.54 - $35.74 $1.61 Million - $3.11 Million	86,900 Added 192.68%	132,000 $4.72 Million
Q2 2021 Aug 16, 2021	SELL	$19.79 - $26.99 $423,506 - $577,586	-21,400 Reduced 32.18%	45,100 $893,000
Q1 2021 May 18, 2021	BUY	$18.57 - $25.68 $102,135 - $141,240	5,500 Added 9.02%	66,500 $1.55 Million
Q4 2020 Feb 17, 2021	BUY	$15.26 - $28.61 $729,428 - $1.37 Million	47,800 Added 362.12%	61,000 $1.27 Million
Q3 2020 Nov 17, 2020	BUY	$20.58 - $28.96 $92,609 - $130,320	4,500 Added 51.72%	13,200 $286,000
Q2 2020 Aug 17, 2020	SELL	$11.15 - $24.64 $24,530 - $54,208	-2,200 Reduced 20.18%	8,700 $205,000
Q1 2020 May 15, 2020	BUY	$8.75 - $16.3 $95,375 - $177,670	10,900 New	10,900 $129,000

407

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.31B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.